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Abstract. 
 
The type 3 ryanodine receptor (RyR3) is a 
ubiquitous calcium release channel that has recently 
been found in mammalian skeletal muscles. However, 
in contrast to the skeletal muscle isoform (RyR1), nei-
ther the subcellular distribution nor the physiological 
role of RyR3 are known. Here, we used isoform-spe-
ciﬁc antibodies to localize RyR3 in muscles of normal 
and RyR knockout mice. In normal hind limb and dia-
phragm muscles of young mice, RyR3 was expressed in 
all ﬁbers where it was codistributed with RyR1 and 
with the skeletal muscle dihydropyridine receptor. This 
distribution pattern indicates that RyR3 is localized in 
the triadic junctions between the transverse tubules and 
the sarcoplasmic reticulum. During development, 
RyR3 expression declined rapidly in some ﬁbers 
whereas other ﬁbers maintained expression of RyR3 
into adulthood. Comparing the distribution of RyR3-
containing ﬁbers with that of known ﬁber types did not 
show a direct correlation. Targeted deletion of the 
RyR1 or RyR3 gene resulted in the expected loss of the 
targeted isoform, but had no adverse effects on the ex-
pression and localization of the respective other RyR 
isoform. The localization of RyR3 in skeletal muscle tri-
ads, together with RyR1, is consistent with an accessory 
function of RyR3 in skeletal muscle excitation–contrac-
tion coupling.
Key words: skeletal muscle • calcium release channel 
• excitation–contraction coupling • immunoﬂuores-
cence • knockout mice
 
R
 
yanodine
 
 receptors (RyR)
 
1
 
 comprise a class of three
calcium release channels that are encoded by sepa-
rate genes (Sorrentino, 1995; Sutko and Airey,
1996). The skeletal muscle isoform type 1 (RyR1) and the
cardiac isoform type 2 (RyR2) are essential for excitation–
contraction coupling in skeletal and heart muscle, respec-
tively (Marks et al., 1989; Takeshima et al., 1989; Nakai
et al., 1990; Otsu et al., 1990; Zorzato et al., 1990). The
type 3 isoform (RyR3) is expressed in many tissues, in-
cluding the brain and skeletal muscles (Giannini et al.,
1992, 1995). However, the physiological role of RyR3 is
not known.
In skeletal muscle RyR1 is localized in the triad junc-
tion, where it closely interacts with the dihydropyridine re-
ceptor in depolarization-induced calcium release from the
sarcoplasmic reticulum (SR; Flucher and Franzini-Arm-
strong, 1996; Franzini-Armstrong and Protasi, 1997). In re-
sponse to depolarization of the transverse (T)-tubules, the
dihydropyridine receptor, the physiological voltage-sen-
sor, rapidly activates the opening of the RyR1 without the
necessity of conducting calcium by itself (Melzer et al.,
1995). In turn, the dihydropyridine receptor receives sig-
nals from the RyR1 that modulate its L-type calcium chan-
nel properties (Fleig et al., 1996; Nakai et al., 1996). In or-
der for such a close interaction to occur, the two channels
are coordinately arranged in the opposing junctional
membranes (Block et al., 1988). The clover leaf shaped cy-
toplasmic foot of every other RyR homotetramer in the
SR membrane faces a group of four dihydropyridine re-
ceptors, called tetrads, in the T-tubule membrane. Current
models of skeletal muscle excitation–contraction coupling
regard the dihydropyridine receptor-coupled RyRs as di-
rectly under the control of membrane depolarization, and
the uncoupled RyRs as indirectly regulated by calcium-
induced calcium release (Stern et al., 1997).
Biochemical studies have shown that most of avian, am-
phibian, and fish skeletal muscles contain two RyR iso-
 
forms, 
 
a
 
 and 
 
b
 
 (Sutko et al., 1991), which correspond
to mammalian RyR1 and RyR3, respectively (Oyamada et
al., 1994; Ottini et al., 1996). Recent evidence indicates
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that RyR3 is also expressed in mammalian muscles, al-
though at lower levels than RyR1 (Giannini et al., 1992,
1995). In mammals, the two isoforms are differentially ex-
pressed during development, as well as in different muscle
types (Conti et al., 1996; Bertocchini et al., 1997; Tarroni
et al., 1997). RyR3 is detected by Western blot analysis in
all skeletal muscles of late embryonic stage and during the
first two weeks after birth, however, it is downregulated in
most mammalian muscles of adult animals with the excep-
tion of diaphragm and soleus muscles.
A central role for the RyR1 isoform in skeletal muscle
is indicated by the observation that homozygous RyR1
knockout mice die upon birth from respiratory failure
(Takeshima et al., 1994). The phenotype of these mice is
similar to that of the cn/cn chicken mutant which also does
not express RyR1 (Ivanenko et al., 1995). In both cases,
excitation–contraction coupling is lost despite the fact that
the muscle cells express considerable amounts of RyR3
(Ivanenko et al., 1995; Takeshima et al., 1995). In agree-
ment with this observation, expression of exogenous RyR2
and RyR3 in RyR1
 
2
 
/
 
2
 
 myotubes did not rescue excita-
tion–contraction coupling. Together, these studies demon-
strated that only RyR1 is capable of establishing a func-
tional coupling with the voltage sensor. In contrast, all
three channel isoforms can be activated by calcium (Ya-
mazawa et al., 1996).
At variance with RyR1 knockout, RyR3 knockout mice
are viable and have no major defect of muscle function
(Takeshima et al., 1996). However, consistent with the
neonatal pattern of RyR3 expression, studies on contrac-
tile properties of RyR3 knockout muscles revealed that
the amount of force generated upon electrical stimulation
or following caffeine exposure was strongly depressed in
skeletal muscles from newborn RyR3
 
2
 
/
 
2
 
 mice compared
with normal controls (Bertocchini et al., 1997). This sug-
gests that, at least during early development, RyR3 plays a
role in the amplification of the calcium signal in excita-
tion–contraction coupling.
To understand the role of RyR3 in skeletal muscle func-
tion, it is important to answer the question as to whether
RyR3 is localized in the triad junction or elsewhere in the
muscle fiber, i.e., in extrajunctional calcium stores. Fur-
ther, it is important to determine whether all fibers express
both RyR1 and RyR3 simultaneously during early devel-
opment and then downregulate RyR3 to different degrees,
or whether RyR3 is expressed exclusively by a subset of fi-
bers, which are gradually replaced by RyR1-containing fi-
bers. To this end, we conducted an immunolocalization
study comparing the expression and subcellular distribu-
tion of RyR1 and RyR3 at different developmental stages
in muscles of normal and RyR knockout mice. The results
of this study indicate that RyR3 is localized in the triad
junction and coexpressed with RyR1 in the same muscle
fibers, indicative of an accessory role of RyR3 in skeletal
muscle excitation–contraction coupling.
 
Materials and Methods
 
Mice Strains
 
Generation of RyR1
 
2
 
/
 
2
 
 and RyR3
 
2
 
/
 
2
 
 mice has been described else-
where (Takeshima et al., 1994; Bertocchini et al., 1997). For tissue prepa-
 
ration, normal, homozygous RyR1
 
2
 
/
 
2
 
, and homozygous RyR3
 
2
 
/
 
2
 
 mice
were anesthetized with carbon dioxide, decapitated, and tissue samples
were removed. Small muscle pieces were infiltrated in 5% DMSO in PBS
for 5 to 15 min and then rapidly frozen in precooled 2-methylbutane and
stored at 
 
2
 
70
 
8
 
C. Frozen samples were mounted in OCT compound, sec-
tioned on a cryostat, and the sections were mounted on glass microscope
slides.
 
Immunofluorescence Labeling
 
Tissue sections were rinsed in PBS containing 0.2% BSA and 0.2% Triton
X-100 (PBS/BSA/Triton) and then incubated in 5% normal goat serum
(NGS) in PBS/BSA/Triton for 30 min at room temperature. Then, the sec-
tions were incubated in primary antibody for 4 h at room temperature or
overnight at 4
 
8
 
C and subsequently washed with five changes of PBS/BSA/
Triton for a total of 30 min at room temperature. Sections were then incu-
bated in fluorochrome-conjugated secondary antibody for 1 h at room
temperature and washed as before. The sections were then incubated in
90% glycerol, 0.1 M Tris, pH 8, with 5 mg/ml p-phenylenediamine to re-
tard photobleaching and covered with a coverglass.
The following primary antibodies were used at the indicated concentra-
tions: affinity-purified rabbit antibody against RyR1 at 1:5,000 (AB#5;
Flucher et al., 1993); rabbit antiserum against RyR3 at 1:1,000; mono-
clonal mouse antibody against the skeletal muscle dihydropyridine recep-
tor 
 
a
 
1
 
 subunit at 0.1 mM (mAb 1A; Morton and Froehner, 1987); mono-
clonal mouse antibody against fast isoform of the skeletal muscle Ca
 
2
 
1
 
ATPase, SERCA1 at 1:500 (MA3-911; Affinity BioReagents; Jorgensen
et al., 1988); and monoclonal mouse antibodies against the following iso-
forms of myosin heavy chain, which were generously supplied by Dr. S.
Schiaffino (University of Padova, Italy): antibody BF-G6 against embry-
onic MHC used at 1:4,000; BA-D5 against slow MHC used at 1:500; and
SC-71 against fast red, 2A MHC used at 1:500. Secondary antibodies were
Cy3- and fluorescein-conjugated goat anti–rabbit and goat anti–mouse
IgG (Jackson ImmunoResearch Laboratories) used at a dilution of
1:5,000. All antibodies have been characterized elsewhere and, except
anti-RyR3, extensively used in immunocytochemistry (Flucher et al.,
1993, 1994; Powell et al., 1996).
As controls, primary antibodies were omitted or inappropriate second-
ary antibodies were applied. Isoform-specificity of the RyR antibodies
was evaluated in situ using tissues from the homozygous RyR1
 
2
 
/
 
2
 
,
RyR3
 
2
 
/
 
2
 
 (see Results), and from a double knockout strain of mice for
both RyR1 and RyR3 genes (RyR1
 
2
 
/
 
2
 
 and RyR3
 
2
 
/
 
2
 
; not shown; Bar-
one et al., 1998). Immunostained sections were evaluated and analyzed on
a Zeiss fluorescence microscope and images were captured with a Zeiss la-
ser scanning confocal microscope using the 63
 
3
 
, 1.4 NA, Plan-Apochro-
mat objective lens.
 
Microsomal Vesicle Preparations and Western
Blot Analysis
 
Skeletal muscles isolated from mice at indicated ages were used to pre-
pare the microsomal fractions as previously described (Conti et al., 1996).
Muscles were homogenized in ice-cold buffer A (320 mM sucrose, 5 mM
Na-Hepes, pH 7.4, and 0.1 mM PMSF) using a Dounce homogenizer. Ho-
mogenates were centrifuged at 7,000 
 
g
 
 for 5 s at 4
 
8
 
C. The supernatant ob-
tained was centrifuged at 100,000 
 
g
 
 for 1 h at 4
 
8
 
C. The microsomes were
resuspended in buffer A and stored at 
 
2
 
80
 
8
 
C. Protein concentration of
the microsomal fraction was quantified using the Bradford protein assay
kit (BioRad). Microsomal proteins were separated by SDS/PAGE and
then transferred to a nitrocellulose membrane (Schleicher & Schuell).
Membranes were incubated for 3 h in 150 mM NaCl, 50 mM Tris-HCl, pH
7.4, 0.2% Tween 20, plus 5% nonfat milk. Primary antibodies used were
polyclonal rabbit antisera (diluted 1:3,000) against the RyR isoform (Gi-
annini et al., 1995). Antigen detection was performed using the amplified
alkaline phosphatase detection method.
 
Results
 
Expression of RyR1 and RyR3 in Embryonic Muscles of 
Wild-type and Knockout Mice
 
To determine to what extent RyR3 is expressed in devel-
oping skeletal muscle and whether it is coexpressed with
RyR1 in the same fibers, unfixed cryosections of muscles 
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from normal, homozygous RyR1
 
2
 
/
 
2
 
, and homozygous
RyR3
 
2
 
/
 
2
 
 mice at embryonic day 18 (E18) were immuno-
labeled with specific antibodies against RyR1 and RyR3
(Fig. 1). In wild-type muscles, both RyR antibodies stained
all myofibers with similar intensity, indicating that, at this
developmental stage, RyR1 and RyR3 are coexpressed in
mouse skeletal muscles. The labeling patterns for both
RyR isoforms were punctate and irregularly distributed
throughout the myoplasm (Fig. 1, a and b), resembling the
distribution pattern of triad proteins that is typically found
in E18 muscle fibers. Since the nuclei were still centrally
located in the myofibers, the labeling pattern appeared
ring-shaped in cross-sections. RyR1
 
2
 
/
 
2
 
 muscles were la-
beled with anti-RyR3, but not with anti-RyR1 (Fig. 1, c
and d). Conversely, RyR3
 
2
 
/
 
2
 
 muscles were labeled with
anti-RyR1, but not with anti-RyR3 (Fig. 1, e and f). This is
consistent with previous immunoblot experiments (Ber-
 
tocchini et al., 1997) and shows that there are no cross-
reactions of anti-RyR1 with RyR3 and of anti-RyR3 with
RyR1. Thus, the immunofluorescence assay is highly spe-
cific for the respective RyR isoforms. Furthermore, the
absence of immunostain with anti-RyR3 and anti-RyR1 in
muscles of RyR1
 
2
 
/
 
2
 
 and RyR3
 
2
 
/
 
2
 
 mice, respectively,
provides additional evidence that the targeted mutations
of the genes encoding the RyR isoforms resulted in the
complete and specific loss of the respective proteins. Ex-
pression of RyR3 in skeletal muscles of RyR1
 
2
 
/
 
2
 
 mice
was also observed in a second independent RyR1 knock-
out mouse strain (data not shown) generated by Dr. P.D.
Allen (Brigham and Women’s Hospital, Boston, MA).
Normal expression of RyR1 in RyR3
 
2
 
/
 
2
 
 mice was also
detected in skeletal muscles from mice 15-, 25-, and 60-
d-old (D15, D25, and D60; not shown).
 
RyR3 and RyR1 Are Localized in Triads
 
If RyR3 is involved in the initial aspects of excitation–con-
traction coupling, then its localization in the triad would
be expected. With fluorescent microscopy, triad proteins
exhibit characteristic labeling patterns (Figs. 2 and 3). In
longitudinal sections of differentiated skeletal muscles, a
cross-striated banding pattern with a center-to-center dis-
tance between the bands of 
 
z
 
2 
 
m
 
m can be seen. At higher
resolution, the cross-striated bands can be identified as
double rows of fluorescent dots, representing the pairs of
triads on either sides of the Z-line. Pairs of neighboring
fluorescent dots are aligned along the myofibril bundles.
In cross-sections, triad proteins show a network of mem-
branes encircling the myofibril bundles. Fig. 2 compares
the distribution pattern of a known triad protein, the 
 
a
 
1
 
subunit of the dihydropyridine receptor (Fig. 2, a–c), with
that of RyR3 (Fig. 2, d–f) in D15 normal diaphragm mus-
cle. The distribution of the RyR3 immunolabel shows the
characteristics of a triad protein, most importantly the
double rows of fluorescent dots (Fig. 2 f). The fact that a
T-tubule protein, the dihydropyridine receptor, and a SR
protein, RyR3 (or RyR1) stain the same cytoplasmic struc-
ture is further evidence that this structure represents the
T-tubule/SR junction, i.e., the triad. No other cytoplasmic
structure showed significant RyR3 label. Thus, RyR3 is lo-
calized in the triad junctions of skeletal muscle and not to
any significant amount in other regions of the ER/SR
system.
The coextensive labeling patterns of RyR1 and RyR3
observed in E18 hind limb muscles (Fig. 1) combined with
the localization of RyR3 immunolabel in the triads of dif-
ferentiated muscle (Fig. 2) suggests that the two RyR iso-
forms coexist in the same triads. Fig. 3 allows the direct
comparison of the subcellular distribution of RyR3 with
that of RyR1 in D15 normal mouse diaphragm. Specific
antibodies against RyR1 and RyR3 labeled all muscle fi-
bers to the same extent and the two RyR isoforms showed
identical triad labeling patterns in longitudinal and cross-
sections. Thus, RyR3 and RyR1 coexist in, or in close
proximity to, young skeletal muscle triads. Triad staining
of RyR3, as shown for D15 diaphragm in Fig. 3 was also
observed in RyR3-expressing fibers from hind limb mus-
cles (not shown) and from muscles of later developmental
stages. However, in older muscles, RyR3 was not ex-
Figure 1. Expression of RyR1 and RyR3 in E18 muscles of wild-
type and RyR knockout mice. Cross-sections of normal (a and
b), RyR12/2 (c and d), and RyR32/2 (e and f) hind limb mus-
cles were immunofluorescence-labeled with specific antibodies
against RyR1 (a, c, and e) and RyR3 (b, d, and f). RyR1 is ex-
pressed in all fibers of wild-type and RyR32/2 muscles, but not
in RyR12/2 muscles. RyR3 is expressed in all fibers of wild-type
and RyR12/2 muscles, but not in RyR32/2 muscles. No cross-
reaction between anti-RyR1 and RyR3, or anti-RyR3 and RyR1
was observed. N, centrally located nuclei. Bar, 20 mm. 
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pressed uniformly in all muscle fibers, but only in a subset
of fibers. Fig. 4 shows an example of normal D25 dia-
phragm labeled with antibodies against RyR1 and RyR3.
Whereas anti-RyR1 uniformly stained all muscle fibers in
the fields, only one fiber in each field is stained with anti-
RyR3. These RyR3-positive muscle fibers were labeled as
intensively as those of D15 and also expressed RyR1 (Fig.
4, c and d). This shows that, during postnatal development,
the majority of muscle fibers lose RyR3 from their triads.
However, those fibers that continue to express RyR3 also
express RyR1.
 
Differential Downregulation of RyR3 in Diaphragm 
and Hind Limb Muscles
 
The finding described above indicates that the RyR3 con-
tent does not decrease gradually and simultaneously in all
muscle fibers, but that it decreases rapidly in some fibers
and not in others. Fig. 5 shows that during postnatal devel-
opment the number of RyR3-containing fibers dramati-
cally decreases with age and that this occurs at different
rates in different muscles. Whereas RyR3-positive fibers
could be found even in adult (D60) diaphragm muscle, ex-
tensor digitorum longus (EDL) muscle was devoid of
RyR3-positive fibers as early as D25. Semiquantitative
analysis showed that in diaphragm, the decline in numbers
 
of RyR3-containing fibers did not begin until after D15.
By D60, only 13% of the fibers were positive for RyR3.
In contrast, in EDL the fraction of RyR3-containing fi-
bers declined to 17% by D15 and disappeared before
D25. The overall morphology of the RyR3-containing fi-
bers gave no indication that these fibers were different or
at a different stage of differentiation than the neighbor-
ing RyR3-lacking fibers in the section. Comparison of the
tissue distribution of RyR3 with the fiber type composi-
tion of the studied muscles did not suggest a correlation
of the RyR3-containing fibers with a distinct fiber type
(Conti et al., 1996). Comparison of the fractions of RyR3-
containing fibers with fibers labeled with specific anti-
bodies against myosin heavy chain isoforms of embry-
onic, slow, and fast (2A) fibers, or with an antibody
against the fast calcium ATPase, also failed to show any
correlation of RyR3 expression with a specific fiber type
(Table I). For instance, in D15 diaphragm, 100% of the fi-
bers were positive for RyR3, but only 10%–80% of the fi-
bers reacted with any one of the fiber type markers. Con-
versely, in D25 EDL muscle, none of the fibers contained
RyR3, whereas between 5 and 30% of the fibers reacted
with one of the tested markers. As to the onset of RyR
expression during embryonic development, we observed
both RyR1 and RyR3 in leg muscles fibers at E14 (not
shown).
Figure 2. Colocalization of RyR3 and the skeletal muscle dihydropyridine receptor in mouse skeletal muscle. Cryostat sections of D15
normal mouse diaphragm muscles were immunolabeled with specific antibodies against the a1 subunit of the dihydropyridine receptor
(a–c) and against RyR3 (d–f). Longitudinal sections (a, c, d, and f) show cross-striations of double rows of fluorescent dots with both an-
tibodies. Cross-sections (b and e) reveal a labeled meshwork of tubular structures. The colocalization of a junctional T-tubule protein
(dihydropyridine receptor) with the RyR3 identifies the labeled structure as T-tubule/SR junction. Bars, 5 mm. 
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Western Blot Analysis of RyR1 and RyR3 in Newborn 
and Adult Diaphragm and Hind Limb Muscles
 
To directly correlate the immunocytochemical data with
the relative content of RyR1 and RyR3 in crude mem-
brane preparations of developing hind limb muscles and
diaphragm, muscle tissue was isolated from mice at D2
and D15, and from adult mice (i.e., D60) and subsequently
analyzed in Western blots. As shown in Fig. 6, the expres-
sion patterns of RyR1 and RyR3 differ between hind limb
and diaphragm muscles. In neonatal mice, levels of RyR1
and RyR3 are higher in diaphragm than in hind limb mus-
cles. In D2 and D15 diaphragm, RyR3 was found at similar
levels, while in hind limb muscles, RyR3 levels increased
markedly during the same period. A similar expression
pattern (steady expression within the first two weeks after
birth in diaphragm and an increase in expression in hind
limb muscles) was observed for the RyR1 isoform. In line
with previous results, RyR3 expression was reduced below
the level of detection in hind limb muscles of adult ani-
mals. In contrast, in diaphragm, RyR3 was still detected in
adult animals, although at lower levels. These experiments
were repeated with five different microsome preparations,
always confirming the expression pattern reported in Fig.
6. Densitometric analysis of seven representative Western
blots from these experiments indicate a 5–10-fold differ-
ence in RyR3 content of diaphragm of newborn and adult
mice, which is consistent with the decreased number of
muscle fibers expressing RyR3, as observed with immuno-
cytochemistry.
 
Discussion
 
Most of our current knowledge of the physiological role of
RyRs is derived from studies of RyR1 and RyR2 in stri-
ated muscles, where these two RyR isoforms function in
depolarization-induced calcium release from the SR. The
skeletal muscle RyR1 is controlled directly by the voltage
sensor, the dihydropyridine receptor, whereas the cardiac
RyR2 opens in response to calcium entering through the
dihydropyridine receptor and calcium being released else-
where from the SR. In contrast, we know little about the
biological functions of the ubiquitously expressed RyR3
isoform. Studying RyR3 in skeletal muscle, where we un-
derstand the mechanisms of calcium regulation best, may
give us important insights into its physiological role.
RyR3 is not essential for muscle function and it cannot
substitute for the function of RyR1 in skeletal muscle. Ex-
pression of RyR3 is downregulated during early develop-
ment and some adult mammalian muscles, like EDL, do
not express RyR3. Furthermore, RyR3
 
2
 
/
 
2
 
 mice develop
and move normally. However, depolarization-induced cal-
cium release is weaker in young RyR3
 
2
 
/
 
2
 
 muscle fibers
than in normal fibers (Bertocchini et al., 1997). Thus, it has
been suggested that RyR3 may play an accessory function
Figure 3. Colocalization of RyR1 and RyR3 in young mouse skeletal muscle. Sections of D15 normal mouse diaphragm muscles were
immunolabeled with specific antibodies against RyR1 (a–c) and RyR3 (d–f). Both antibodies show the typical labeling pattern of triad
proteins: double rows of fluorescent dots representing the pairs of triads on either sides of the Z-line or the meshwork between the
myofibrillar bundles, in longitudinally (a, c, d, and f) and cross-sectioned (b and e) muscle fibers, respectively. Bars, 5 mm. 
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in skeletal muscle excitation–contraction coupling. This
hypothesis is strongly supported by our present finding
that RyR3 is localized in skeletal muscle triads. The immu-
nolocalization pattern of RyR3 resembled exactly that of
RyR1 in young mammalian muscle fibers and the colocal-
ization of RyR3 with the skeletal muscle dihydropyridine
receptor indicates that the RyR3-containing structure
corresponds to T-tubule/SR junctions. This finding is in
agreement with the preferential distribution of RyR3 in
the heavy SR fraction (Conti et al., 1996). Within the triad,
the observed immunofluorescence labeling pattern is
consistent with one of two possible subcellular localiza-
tions. Either RyR3 is interspersed between RyR1 in the
junctional face of the terminal SR cisternae, or RyR3
and RyR1 are localized adjacent to each other in sepa-
rate membrane domains. The alternating organization of
the RyRs, with respect to the dihydropyridine receptors
(Block et al., 1988), would allow RyR3 to occupy the posi-
tions of the uncoupled RyRs within the junction. The pref-
erential association of dihydropyridine receptors with ev-
ery other RyR foot structure during early formation of
junction (Protasi et al., 1997) is suggestive of an alternat-
ing organization of two different RyR isoforms within
these junctions: one that associates with dihydropyridine
receptors and one that does not. However, even if an alter-
nating organization of RyR1 and RyR3 would exist in de-
veloping muscle fibers, this can hardly be the mechanism
by which this molecular arrangement of the dihydropyri-
dine receptor tetrads is formed, because muscles that do
not express RyR3 have been shown to contain alternating
coupled and uncoupled RyRs (O’Brien et al., 1993). Al-
ternatively, the RyR3 could occupy regions adjacent to
the RyR1-containing junctional domain. This arrange-
ment would be more consistent with the observation that
junctions of the RyR1
 
2
 
/
 
2
 
 mouse, in which we detect
RyR3 with immunofluorescence labeling, apparently lack
feet and are significantly narrower than normal T-tubule/
SR junctions (Takekura et al., 1995). However, in that and
another report (Takeshima et al., 1995), junctions with few
feet have occasionally been found. Whether RyR3 is lo-
cated in one or the other of these two domains of the ter-
minal SR cisternae has implications on current models of
excitation–contraction coupling (Stern et al., 1997). But ei-
ther location, within or adjacent to the junctional face,
would be consistent with a role of RyR3 in the amplifica-
tion of calcium release immediately after initiation of de-
polarization-induced calcium release.
The fact that RyR3 was not localized in any com-
partments other than the triad is also important. Even
though immunolabeling does not exclude the possibility
Figure 4. Differential expression of RyR1 and RyR3 in D25 dia-
phragm muscle. Longitudinal and cross-sections of D25 mouse
diaphragm muscle were immunolabeled with antibodies against
RyR1 (a and c) and RyR3 (b and d). Anti-RyR1 stains all muscle
fibers, but anti-RyR3 stains only a fraction of the muscle fibers at
this developmental stage. Serial sections (c and d) show that the
fiber that expresses RyR3 (d) also contains RyR1 (c). Bar, 10 mm.
Figure 5. Differential decline
of RyR3-expressing muscle fi-
bers in developing diaphragm
and hind limb muscles. Cross-
sections of diaphragm (a–d),
hind limb (e), and extensor dig-
itorum longus (EDL; f–h) mus-
cles from mice at E18 and D15,
D25, and D60 were immunola-
beled with an antibody against
RyR3. In diaphragm, RyR3
was expressed in all fibers up to
D15 and was still found in a
small fraction of fibers at D60.
While E18 hind limb muscle
expressed RyR3 in all fibers,
RyR3 expression in EDL de-
clined rapidly after birth. Bar,
10 mm. 
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that RyR3 is expressed at low concentrations in other re-
gions of the SR, its distribution pattern was clearly that of
a triad protein and distinct from that of the calcium ATP-
ase, which is concentrated in the longitudinal SR (Jor-
gensen et al., 1988; Flucher et al., 1993). Thus, it is rather
unlikely that RyR3 would primarily serve general house-
keeping functions in developing muscles and that its con-
tribution to excitation–contraction coupling would be only
secondary. In cardiac ventricular muscle, SR calcium
stores have been observed (extended or corbular SR) that
contain RyRs, but are not coupled to dihydropyridine re-
ceptors (Jorgensen et al., 1993; Carl et al., 1995). Presum-
ably, these calcium release sites serve in the wave-like
propagation of the calcium signal into the interior of the
cardiac myocytes. The properties of RyR3 would be con-
sistent with a similar function in skeletal muscle, but such
structures have not been described in skeletal muscle, and
our immunolocalization does not indicate the existence of
calcium release sites outside the triads either. Thus, the
lack of RyR3 immunolocalization outside the triad junc-
tions further supports the notion that the primary biologi-
cal role of RyR3 in skeletal muscle is in excitation–con-
traction coupling. This is in agreement with the results of
several recent functional studies of the RyR3 (Chen et al.,
1997; Murayama and Ogawa, 1997; Sonnleitner et al.,
1998), which indicate that RyR3 channels are less sensitive
to inactivation at high calcium concentrations than RyR1.
Thus, the function of RyR3 in the skeletal muscle triad
 
could be to amplify the calcium signal coming from the di-
rectly voltage-activated RyR1 channels (Sorrentino and
Reggiani, 1999).
The developmental expression of RyR3 differs from
that of RyR1. The earliest stage in which we looked for
RyR3 expression in skeletal muscle was E14. Even at this
time in development, RyR1 and RyR3 were both coex-
pressed in mouse muscle fibers. This differs from the on-
set of expression of the corresponding RyR isoform in
chicken, where the 
 
a
 
 RyR precedes the 
 
b 
 
RyR by as much
as five days (Sutko et al., 1991). At E18, all hind limb and
diaphragm muscle fibers expressed both RyR isoforms. At
this developmental stage, hind limb and diaphragm mus-
cles of RyR1
 
2
 
/
 
2
 
 mice also contained normal concentra-
tions of RyR3 (Bertocchini et al., 1997). This finding is
consistent with data showing the expression of RyR3 mes-
sage and the ryanodine and caffeine sensitivity in RyR1
 
2
 
/
 
2
 
myotubes (Takeshima et al., 1995), but it contradicts the
results of Buck et al. (1997), who did not detect ryanodine
binding or RyR3 immunoreactivity in muscles of a differ-
ent RyR1 knockout mouse. To rule out that our positive
RyR3 immunoreaction resulted from a peculiarity of one
particular RyR1 knockout mouse, we performed the im-
munofluorescence experiments on muscles from RyR1
 
2
 
/
 
2
 
mice generated in two different laboratories (Takeshima
et al., 1994; Nakai et al., 1996). In both cases we found
RyR3 label in triads of embryonic muscle.
Soon after birth, expression levels of RyR3 began to de-
cline, first in EDL muscle and later in diaphragm. This
time course was expected from our earlier results of a
Western blot analysis (Bertocchini et al., 1997; Tarroni
et al., 1997). However, to our surprise, the loss of the
RyR3 isoform in developing muscles occurred not by a
continuous decline of RyR3 throughout the muscle, but
occurred rapidly in some fibers and delayed or not at all in
others.
Available estimates of RyR3 content in adult diaphragm
indicate that the content of this isoform varies between 0.7
and 5% of total RyRs in whole muscle homogenates (Mu-
rayama and Ogawa, 1997; Jeyaknmar et al., 1998). Our
Western blot analysis revealed a 5–10-fold reduction in the
RyR3 levels of adult diaphragm compared with newborn
diaphragm. Immunostaining results presented in Figs. 4
and 5 show that all fibers of skeletal muscles of fetal and
newborn mice contain RyR3, while in adult diaphragm,
only a subset of 
 
z
 
10–15% of the fibers contain RyR3. To-
gether, these findings suggest that the developmental de-
cline in RyR3 protein in adult diaphragm results from the
decreased number of RyR3 positive fibers. At the same
 
Table I. Comparison of RyR3 Expression and Expression of Fiber Type-specific Myosin Heavy Chains and SR Ca
 
2
 
1
 
 ATPase in 
Developing Hind Limb and Diaphragm Muscles
 
Antibody to
E18 D15 D25 D60
Diaphragm Hind limb Diaphragm EDL Diaphragm EDL Diaphragm EDL
 
% % %%%%%%
 
RyR3 100 100 100 16.8 21.8 0 13.4 0
Slow MHC 10.8 17.2 8.8 4.8
Fast MHC (2A fibers) 38.4 31.8 41.3 27.9
SERCA1 (fast) 79.9 93.2
 
Number of fibers counted for each condition ranged between 101 and 397.
Figure 6. Developmental expression of the RyR1 and RyR3 iso-
forms in murine diaphragm and hind limb muscles. Microsomes
were prepared from hind limb and diaphragm muscles of 2-d-old
(2d), 15-d-old (15d), and adult mice (60d). 3 and 10 mg of mi-
crosomal vesicles were loaded for RyR1 and RyR3 immunode-
tection, respectively. In all experiments, 10 and 30 mg from bo-
vine diaphragm were loaded as control (ctr) for RyR1 and RyR3
immunodetection, respectively. Western blot analysis was per-
formed, as described in the text. 
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time, it can be inferred that the content of RyR3 in the subset
of fibers expressing this isoform in adult mouse diaphragm
is roughly the same as that of newborn fibers. This is of par-
ticular importance since it indicates that the relative amount
of RyR3 in skeletal muscle fibers that express this isoform
is higher than previously appreciated from biochemical es-
timates based solely on total muscle homogenates.
With the aim of correlating the RyR3-expressing fibers
with a functional muscle fiber type, we compared the ex-
pression pattern of RyR3 in D15 and D25 diaphragm and
EDL muscles with those of different isoforms of the myo-
sin heavy chain and with that of the fast calcium ATPase.
However, the expression pattern of none of these marker
proteins mirrored that of RyR3, indicating that the regula-
tion of RyR3 expression in developing mammalian mus-
cles is independent of regulation of the fiber-type specific
set of proteins. This result is supported by data from an
earlier denervation experiment in which no changes of
RyR3 expression levels were observed after denervation
(Tarroni et al., 1997), even though the fiber type composi-
tion is known to change after denervation (Schiaffino et al.,
1988). Thus, neither the physiological function of RyR3
nor the regulation of its expression are directly correlated
with a single specific fiber type.
The differential regulation of RyR3 expression in differ-
ent muscle fibers suggests a functional difference between
the fibers that contain RyR3 in addition to RyR1 and
those that do not. The physiological significance of a sec-
ond RyR isoform in a skeletal muscle triad is not clear, al-
though expression of two isoforms of RyRs is common in
nonmammalian vertebrate skeletal muscles (Sutko and
Airey, 1996). Two components of Ca
 
2
 
1
 
 release can be
identified in voltage clamp experiments: one that is strictly
related to membrane depolarization and a second with fast
activation and inactivation properties, presumably repre-
senting Ca
 
2
 
1
 
-induced Ca
 
2
 
1
 
 release (Rios et al., 1992).
While RyR1 alone seems to be able to support both com-
ponents of Ca
 
21 release, as they have also been observed
in muscle fibers containing only a single RyR isoform, a
second RyR isoform with different properties of Ca21-
dependent activation and inactivation may affect the Ca21
release component that is not under the direct control of
membrane depolarization (see Stern et al., 1997).
In summary, the results of this study demonstrate that
considerable amounts of RyR3 are expressed in the triads
of skeletal muscle where it can perform an accessory func-
tion to that of RyR1 in excitation–contraction coupling.
Based on the expression pattern in developing muscles,
the function of RyR3 appears to be important for all mus-
cles during early development, but only to a subset of mus-
cle fibers of certain adult muscles.
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